STALEY CAPITAL ADVISERS’s AbbVie ABBV Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$375K	Sell	1,726 -250	-13%	-$55.5K	0.02%	142
2025 Q4	$451K	Hold	1,976	–	–	0.02%	138
2025 Q3	$458K	Hold	1,976	–	–	0.02%	141
2025 Q2	$367K	Hold	1,976	–	–	0.02%	149
2025 Q1	$414K	Hold	1,976	–	–	0.02%	146
2024 Q4	$351K	Hold	1,976	–	–	0.02%	150
2024 Q3	$390K	Hold	1,976	–	–	0.02%	148
2024 Q2	$339K	Buy	1,976 +81	+4%	+$13.4K	0.02%	152
2024 Q1	$345K	Hold	1,895	–	–	0.02%	149
2023 Q4	$294K	Sell	1,895 -600	-24%	-$87.5K	0.01%	152
2023 Q3	$372K	Sell	2,495 -260	-9%	-$38.2K	0.02%	139
2023 Q2	$371K	Buy	2,755 +12	+0.4%	+$1.76K	0.02%	142
2023 Q1	$437K	Hold	2,743	–	–	0.02%	133
2022 Q4	$443K	Hold	2,743	–	–	0.03%	119
2022 Q3	$368K	Buy	2,743 +281	+11%	+$40.3K	0.02%	126
2022 Q2	$377K	Hold	2,462	–	–	0.02%	124
2022 Q1	$399K	Sell	2,462 -500	-17%	-$72.6K	0.02%	133
2021 Q4	$401K	Hold	2,962	–	–	0.02%	137
2021 Q3	$320K	Sell	2,962 -300	-9%	-$34.3K	0.02%	146
2021 Q2	$367K	Sell	3,262 -150	-4%	-$16.9K	0.02%	141
2021 Q1	$369K	Buy	3,412 +150	+5%	+$16K	0.02%	140
2020 Q4	$350K	Buy	3,262 +500	+18%	+$48K	0.02%	137
2020 Q3	$242K	Hold	2,762	–	–	0.02%	146
2020 Q2	$271K	Buy	+2,762	New	+$243K	0.02%	133

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STALEY CAPITAL ADVISERS's ABBV Position: Q1 2026 in Review

STALEY CAPITAL ADVISERS reduced its AbbVie (ABBV) stake by 13% in Q1 2026, selling an estimated $55.5K and leaving 1,726 shares worth $375K. The position accounts for 0.02% of the portfolio, ranked #142.

STALEY CAPITAL ADVISERS first reported a position in ABBV in Q2 2020 and has held it in 24 quarters since. The position peaked at $458K in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

STALEY CAPITAL ADVISERS held 1,726 shares of AbbVie worth $375K as of Q1 2026.
STALEY CAPITAL ADVISERS sold 250 AbbVie shares in Q1 2026, an estimated $55.5K.
AbbVie made up 0.02% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #142 holding.
STALEY CAPITAL ADVISERS first reported a position in AbbVie in Q2 2020 and has held it in 24 quarters since.
STALEY CAPITAL ADVISERS's AbbVie position peaked at $458K in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.